Bristol Flying Solo As A Pure Biopharma After Mead Johnson Spin Out
This article was originally published in The Pink Sheet Daily
Executive Summary
Decision to split off the nutritionals unit - Bristol's last diversified business - reflects management's improved confidence in the biopharma business and strength of Mead Johnson's stock price.